{
    "title": "GSK, partner Vir join race to find COVID-19 antibody treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8681497/GSK-partner-Vir-join-race-COVID-19-antibody-treatment.html",
    "date": "2020-08-31",
    "keywords": [
        "antibody",
        "virus",
        "covid19",
        "trial",
        "part",
        "vir",
        "class",
        "ability",
        "year",
        "role",
        "approach",
        "system",
        "partner",
        "biotechnology",
        "earlystage",
        "race",
        "winner",
        "drugmaker",
        "monday",
        "longacting",
        "injection",
        "highrisk",
        "hospitalisation",
        "life",
        "disease",
        "stage",
        "gsk",
        "april",
        "regeneron",
        "manufacturing",
        "roche",
        "twoantibody",
        "combination",
        "firm",
        "month",
        "compound",
        "covid",
        "september",
        "clinic",
        "bit",
        "time",
        "bestinclass",
        "executive",
        "george",
        "shot",
        "viruss",
        "outer",
        "spike",
        "protein",
        "tendency",
        "drug",
        "safety",
        "end",
        "quarter",
        "access",
        "june",
        "pandemic",
        "effort",
        "vaccine",
        "latestage",
        "work",
        "overreaction",
        "cytokine",
        "storm",
        "bodys",
        "immune",
        "blood",
        "response",
        "substance",
        "body",
        "astrazeneca",
        "attack",
        "plasma",
        "range",
        "quality",
        "plan",
        "infection",
        "treat",
        "hospital",
        "care",
        "collaboration",
        "reporting",
        "burger",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}